user profile

Last Updated : Dec 15 2025

Little One Nutrition Co
Little One Nutrition Co

Building the first US Goat Milk Infant formula; the closest breastmilk alternative.

  • Enterprise
  • Opportunity

Little One is creating the first modern goat-milk formula designed to be the closest and most gentle alternative to breastmilk; paired with a digital community and AI companion that meet Gen Z parents where they are. More than just formula, we’re building a values-driven platform that empowers feeding freedom, builds trust before launch, and positions Little One as the brand parents choose even before they have a baby.

Business profile
Primary contact
Trish Golderer
Country of incorporation
United States
Headquarters
Collingswood, New Jersey, United States
Type of entity
C Corporation
Diversity, Equity, and Inclusion
Women led
Launch year
2024
Team size
1-10
Sectors & themes
Agriculture, Food security, Health, Nutrition
Target regions
North America
Business highlights
  • Cow’s milk is harder to digest, causing 20% of babies to develop a sensitivity
  • Goat milk is the closest alternative to human breastmilk.
  • Projected to be a $18B industry category, untapped domestically
  • Mom-Founded and team of baby nutrition, medical, and market experts
  • Problem
  • Solution
  • Product / service
  • Projected impact
  • Traction
  • Business model
  • Market & competition
  • Vision & strategy

Problem

Cow’s milk is harder to digest, causing 20% of babies to develop a sensitivity; which is a $2 billion dollar problem in the US.

Solution

Goat Milk is the closest alternative to human breastmilk. We're creating THE first line of defense infant formula for the 80% of families who choose formula feeding. Our formula presents the ability for; 

  • preventing dairy allergies
  • stronger immune system
  • better gut health
  • longer sleep
  • faster digestion

Product / service

Goat Milk naturally has the goods & we add science to perfect it. We want the purest goat milk formula on the market. Goat whole milk, whey, & lactose. Our formula is milked and manufactured in the US. Securing our baby food supply chain. From HMOs, MFGMs, to smaller and softer curds, our formula digests easier and keeps babies asleep longer than cow milk formula. 

Traction

  • $150K committed toward a $250K founder-led SPV via Sydecar, funding full IP ownership and MVP development of our goat milk infant formula.
  • Currently raising a $1.5M Pre-Seed SAFE (10% discount, $10M post-money valuation cap) to finalize FDA pathway and accelerate platform development.
  • Strategic partnerships secured with Hive Founders, Womankind Ventures, and leading infant feeding advisors to drive growth and credibility.
  • Formula formulation completed — modeled to be the closest and most gentle alternative to breast milk, using goat whey protein, goat milk lactose, and lactoferrin.
  • AI-powered “Feeding Freedom” platform (LONI) under development — combining digital support, personalized data insights, and community connection for modern parents.
  • Mothers Society community (rebrand launching November 2025) with an existing 200K+ mom audience from Working Momkind, now expanding into a paid membership model.
  • Upcoming investor dinners — “Feeding Futures” series — confirmed in Philadelphia (11/11), New York City (11/12), and Miami (12/04).
  • Featured at the World Logic Forum for thought leadership on AI and maternal health innovation.
  • Active brand design development — positioning as a design-forward, Gen Z-loved alternative to legacy formula brands (modern, skincare-inspired packaging).

Business model

We will have a Direct to Consumer model while taking advantage of a monthly subscription over the course of our customer lifecycle (9-15 months). $45 per 28oz can with a 55% GP. The average consumer will purchase 6 cans a month leading to MRR of $270 per baby. By feeding 9,000 babies in our first year, we will reach $24,000,000 in revenue.

Market & competition

1. Aussie Bubs Goat Stage 1 - Weakness: contains soy, contains palm oil, not organic, no plant based DHA & imported, not fully FDA approved.
2. Kendamil Goat 0-12 months - Weakness: imported, price, not organic, not fully FDA approved
3. Kabrita - Weakness: skim milk, contains soy & palm, not organic
4. Bobbie Gentle - Weakness: skim COW milk, no HMOs, MFGM, or Prebiotics

Vision & strategy

We are building more than just a nutrition productWe know parents don’t just want a formula, they want to feel supported in their feeding journey. That’s why we acquired one of the largest online mom communities, over 200,000 strong, and soon to be reactivated as the Mothers Society platform. It’s a space for parents to connect, learn, and advocate for feeding autonomy. By activating our community, we’re not only driving awareness for Little One but reshaping the conversation around infant nutrition

Success for us means healthier babies, empowered mothers, and a more sustainable planet. We’re championing feeding autonomy, ensuring parents feel confident in whatever choice they make. We’re also exploring ways to expand accessibility, from WIC alignment to programs like Sponsor a Baby, which would allow families to directly support formula access for those in need. Our world today is built to make parenting, but especially mothering, feel impossible. At Little One we want to SHOW UP; think sponsored front parking spots for expecting and young families, a dedicated play and rest space in major airports, changing tables in the men’s bathroom, and the like.

Leadership
Our story
Like many founders in the baby space, my inspiration started at home. I experienced firsthand the stress and guilt parents feel when navigating feeding choices. As a new mother, I was personally navigating breastfeeding challenges that led to losing my milk supply and then watching my baby get sick on cow milk based formulas. It was only after switching to an European goat milk infant formula that my daughter finally found relief. I grew up around food manufacturing [ my father ran an industrial refrigeration company ] so I always had a front-row seat to the behind-the-scenes of how food gets made. When I saw how outdated and cow-milk-centric the infant formula industry still was in the U.S., I knew there was room to do better. That’s how Little One was born: a goat-milk infant formula designed to be the closest alternative to breast milk, and gentler on tiny tummies.

We'd love to talk with you

 
Contact
Website
https://yourlittleone.co/
Email address
trish@yourlittleone.co
Telephone
2155953718
Address
915 Eldridge Ave, Collingswood, New Jersey, 08107, United States
Country
United States
LinkedIn
https://www.linkedin.com/in/trishgolderer/
Facebook
https://www.linkedin.com/in/trishgolderer/

Join OptImpact

Join OptImpact to learn more about this enterprise and discover other opportunities.

Email:
Location:
Phone:

Biography

Get Full Access

Log in or sign up to access full details of this investment opportunity, explore all network content, and connect with other members of the community.

Login Sign up
Learn more about OptImpact
Help articles
  • How to request access to a diligence process underway?
  • What does closing diligence mean?
  • How do I customize templates?
  • What if I don’t want to use these templates?
  • How can I control who sees my templates?
  • How do I signal investment commitment?
  • How do I invite other people to the 'deal table'?

How to request access to a diligence process underway

Investor users can see, where peer investors allow, when a diligence process is underway or completed. When this is the case, users may contact the organization who leads the diligence process directly, or specifically request access to the diligence process underway in the event that those leading may be keen to include prospective coinvestors or collaborators. This ‘request’ functionality is visible only to investors.

Third parties or other user types may be invited directly to a diligence process by a lead investor by clicking on the “Invite” button on the Diligence tab. Once they accept, these users will have access to the diligence process including a shared Q&A area, a document repository, and a diligence-specific chat area.

What does closing diligence mean

Closing diligence means that an appraisal process led by a prospective investor of an organization seeking debt, grant or equity has been terminated. This may or may not mean that a diligence has effectively been completed; an investor may close said process at any time without further notification of next steps. This effectively closes the Diligence ‘table’ that has been opened and managed by a lead prospective investor. This also closes the process for any other investors or invitees to the ‘diligence table’, regardless of where they have been in the process.

How do I customize templates

In order to customize templates, a Master Administrator can go to the Diligence menu item on the left hand menu of the dashboard, and select ‘templates’. From there, one can either select an existing template from the dropdown under “Select template” or create a new one by clicking on the green “Create” button. All sub-questions in any template may be edited or deleted at any time.

What if I don’t want to use these templates

One does not have to use system templates if they are not helpful, applicable, or practical for user purposes. Simply upload whatever documents you’d like to ‘hold’ on the system and use the messaging tab to communicate with those at the virtual diligence table.

How can I control who sees my templates

Anyone who is invited into the diligence deal room for prospective co-investment alongside your own would be able to see the substance and structure of the templates you have constructed and applied to the diligence Q&A process on the Q&A tab. If you have not applied one of your templates, then others at the deal table will not be able to see it.

It is also worth noting that other team members that you have specified as part of your organization’s team will also be able to see the diligence templates that you have customized, if any.

How do I signal investment commitment

The platform is designed to be as flexible as possible in terms of process. As soon as an investor initiates diligence by clicking on the “Start diligence” button, it is possible from that point onwards at any moment to signal an investment commitment of any kind by clicking on the “Make investment” button at the top right of the Diligence tab. Investments can take the following forms: equity, debt, flexible, grant, equity/debt, equity/grant, convertible or blended - and the investor will be prompted to enter an indicative amount. It’s important to note that this is for signalling purposes only, and is a non-binding commitment.

Any figure entered here will be signaled as committed on the deal profile, and those inside the diligence deal room with the investor will see that he/she has signaled such a commitment; at the same time, a notification will be sent to the prospective recipient organization being reviewed. All binding legal commitments and money transfers happen offline and on the back of completion of proper documentation, for which the platform takes no responsibility. Investors contacts connected to you will not see that you have made this commitment.

How do I invite other people to the 'deal table'

Once Diligence has been initiated by an investor, one can click on the Diligence tab under Opportunity and immediately expand the virtual ‘deal table’ by clicking on “Invite organization”. One can search for different types of organization or by name, and will be required to consent to specific ‘terms of service’ related to sharing knowledge about an opportunity.

  • About OptImpact
  • Homepage
  • About us
  • Contact us
  • Legal Information
  • Terms and Conditions of Use

© Copyright 2025 Artha Networks. All rights reserved.

Artha is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Artha does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Artha takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Artha platform. Artha receives no compensation in connection with the purchase or sale of securities. Impact Organizations are not necessarily seeking funding at the time you are accessing the Website. By using this website you acknowledge that you have read and agree to the Terms and Conditions of Use and Privacy Policy.

Invite organizations to this network
Please enter invitation data in the following format (one invitation per line):

First name, last name, company name, email
Delete comment

Are you sure you want to delete this comment?

Create a URL link that you can share with anyone that will allow the recipient to view your enterprise profile and access your investment opportunity.

Note:  user can share their profile publicly if this has been enabled by network admin under Internal content > Network customizations > Enteprise profile.

Your profile is public now. You can share your profile via the following link: